3 No-Brainer Growth Stocks to Buy in 2023
These stocks all fell by double digits last year.
Why Editas Medicine's Shares Jumped This Week
The gene-editing biotech's shares have had a strong two-week run.
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These companies should be able to carry their momentum well beyond this year.
Is Editas Medicine Stock a Buy Now?
Layoffs and a thin clinical-stage pipeline aren't very encouraging.
2 Surefire Stocks to Buy in 2023 and Hold for at Least the Next Decade
These stocks are growing steadily and have a solid history of enriching shareholders.
3 No-Brainer Stocks to Buy in February
Going with these stocks should be an easy decision.
The 10 Best Stocks to Buy in February 2023
These diversified growth stocks could add rocket fuel to your long-term investing portfolio.
A New Bull Market Could Arrive in February: 3 Stocks to Buy Now
The bulls could be about to take over again. And these stocks are poised to be big winners.
3 Things About CRISPR Therapeutics That Smart Investors Know
The gene-therapy specialist's near-term outlook is quite bullish.
The Best Stocks to Invest $20,000 in Right Now
These healthcare giants have plenty of room left to run.